[Edaily Starin YUN GI BACK Reporter] Disney·Pixar’s “Toy Story 5” has firmly held onto the No. 1 spot at the box office for the 14th consecutive day, despite competition from other films. Having surpassed 1.7 million cumulative viewers, the film continues to enjoy a steady, albeit gradual, box office run. A scene from the animated film “Toy Story 5.” (Photo courtesy of The Walt Disney Company Korea) According to the Korean Film Council’s integrated computer network on the 1st, “Toy Story 5” retained the top spot at the box office on the 30th of last month, drawing 42,011 viewers. Its cumulative audience stands at 1,700,047. “The Eye” took second place. It drew 39,317 viewers that day, bringing its cumulative total to 383,039 and continuing its strong performance in its opening week. Next, “The Swarm” added 15,821 viewers, bringing its cumulative total to 5,744,246 and continuing its long-running success. “Wild Thing” ranked fourth, drawing 10,151 viewers, and its cumulative total rose to 1,253,613. “Supergirl” came in fifth. In terms of advance ticket sales, “Toy Story 5” maintained its No. 1 position, continuing its box office momentum. It was followed by “The Eye,” “Marty Supreme” (which opened that day), and “Greenland 2: Migration.” The film industry expects “Toy Story 5” to continue its steady box office performance for the time being. However, with “Marty Supreme” opening today and launching a full-scale push to attract audiences, attention is focused on whether this will bring changes to the box office landscape. In particular, as “Toy Story 5” continues to draw a steady audience, primarily from the family demographic, the key point of interest in this week’s box office will be how well new releases targeting adult audiences can boost box office performance.
Jeonbuk Bank, a subsidiary of JB Financial Group Co., Ltd.(175330), has become the first bank in South Korea to introduce won-denominated loans linked to digital assets. Initially, the service will be…
GENINUS Inc.(389030)is embarking on experimental research to verify the feasibility of developing actual treatments based on new anti-cancer drug targets identified using artificial intelligence (AI).…
#Onconic Therapeutics Inc. has unveiled a new drug candidate designed to reduce muscle loss that can occur during weight loss when used in combination with existing glucagon-like peptide-1 (GLP-1) cla…